139 related articles for article (PubMed ID: 8003770)
1. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.
Saphier D; Roerig SC; Ito C; Vlasak WR; Farrar GE; Broyles JE; Welch JE
Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine effects of interferon-alpha in the rat.
Saphier D
Adv Exp Med Biol; 1995; 373():209-18. PubMed ID: 7668154
[TBL] [Abstract][Full Text] [Related]
3. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
5. Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat.
Saphier D; Welch JE; Chuluyan HE
Eur J Pharmacol; 1993 May; 236(2):183-91. PubMed ID: 8391456
[TBL] [Abstract][Full Text] [Related]
6. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
7. GABA regulates the rat hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes.
Mikkelsen JD; Bundzikova J; Larsen MH; Hansen HH; Kiss A
Ann N Y Acad Sci; 2008 Dec; 1148():384-92. PubMed ID: 19120132
[TBL] [Abstract][Full Text] [Related]
8. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
Alcaraz C; Vargas ML; Fuente T; Milanés MV
J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
[TBL] [Abstract][Full Text] [Related]
9. Role of brain nicotinic acetylcholine receptor in centrally administered corticotropin-releasing factor-induced elevation of plasma corticosterone in rats.
Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Lianyi L; Wakiguchi H; Yokotani K
Eur J Pharmacol; 2008 Jun; 587(1-3):322-9. PubMed ID: 18423439
[TBL] [Abstract][Full Text] [Related]
10. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
Laorden ML; Fuertes G; González-Cuello A; Milanés MV
J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.
Yamano M; Yuki H; Yasuda S; Miyata K
J Pharmacol Exp Ther; 2000 Jan; 292(1):181-7. PubMed ID: 10604946
[TBL] [Abstract][Full Text] [Related]
12. Reduced activity of the noradrenergic system in the paraventricular nucleus at the end of pregnancy: implications for stress hyporesponsiveness.
Douglas AJ; Meddle SL; Toschi N; Bosch OJ; Neumann ID
J Neuroendocrinol; 2005 Jan; 17(1):40-8. PubMed ID: 15720474
[TBL] [Abstract][Full Text] [Related]
13. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
14. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
15. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
Zelena D; Mergl Z; Makara GB
Brain Res; 2005 Jan; 1031(2):185-93. PubMed ID: 15649443
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice.
Zhou Y; Spangler R; Schlussman SD; Yuferov VP; Sora I; Ho A; Uhl GR; Kreek MJ
Synapse; 2002 Sep; 45(4):220-9. PubMed ID: 12125043
[TBL] [Abstract][Full Text] [Related]
17. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
18. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
[TBL] [Abstract][Full Text] [Related]
19. Central stimulation of adrenocortical secretion by 5-hydroxytryptamine1A agonists is mediated by sympathomedullary activation.
Saphier D; Welch JE
J Pharmacol Exp Ther; 1994 Sep; 270(3):905-17. PubMed ID: 7932203
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
Vining C; Iyer V; Bhatnagar S
J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]